ArticleCurrent oncology (Toronto, Ont.)2026

BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal Impairment.

Alma Habib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.